MedTrace Logo

Functional Microarray Augmentation of Skin Treatment With Lidocaine

NCT01145326 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2017-03-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether co-application of a functional microarray of needles (FMA) speeds the rate at which topical anesthesia is provided. A secondary goal is to determine whether the depth of anesthesia is enhanced.

Conditions

  • Pain Perception
  • Phlebotomy

Interventions

DRUG

4% lidocaine gel application with sham microneedle device

Topical 4% lidocaine gel (LG4) applied to subject, after application of sham microneedle device (FMA).

DRUG

Microneedle-facilitated lidocaine application

Application of 4% lidocaine gel (LG4), after application of microneedle (FMA) device

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Stephen H. Thomas, MD MPH · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145326 on ClinicalTrials.gov